Motif Bio plc: Motif Bio and Hercules Capital Amend Loan and Security Agreement

Medigene AG: Medigene participates at upcoming conferences

Motif Bio plc: Motif Bio Confirms Receipt of Deficiency Notice from Nasdaq

Motif Bio plc: Motif Bio Confirms Meeting Date with U.S. FDA regarding Iclaprim

sterna biologicals invited to present at the Goodwin – Solebury Trout – NASDAQ European Biotech Investor Day 2019

Breath Therapeutics BV: Zambon Completes Transformational Acquisition of Breath Therapeutics

Bencard Allergie GmbH: Management change at Bencard Allergie in Germany – René Kreis takes over general management from Bodo Steinert

Apogenix AG: Excellent Preclinical Efficacy Data of Apogenix’ HERA-GITRL Published in Journal for ImmunoTherapy of Cancer

NUMAFERM closes licensing agreement with PEPDesign

ADL Bionatur Solutions and Amyris Expand Contract to 2020